Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 300 Million CNY | -0.06% |
| 2022 | 300.18 Million CNY | -40.24% |
| 2021 | 502.27 Million CNY | 151.14% |
| 2020 | 200 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 312.01 Million CNY | 4.0% |
| 2024 Q1 | 300 Million CNY | 0.0% |
| 2024 Q3 | 306.9 Million CNY | -3.85% |
| 2023 Q3 | 300 Million CNY | 0.0% |
| 2023 FY | 300 Million CNY | -0.06% |
| 2023 Q4 | 300 Million CNY | 0.0% |
| 2023 Q2 | 300 Million CNY | 0.0% |
| 2023 Q1 | 300 Million CNY | -0.06% |
| 2022 Q3 | 301.06 Million CNY | -39.95% |
| 2022 Q2 | 501.32 Million CNY | -0.05% |
| 2022 Q1 | 501.58 Million CNY | -0.14% |
| 2022 FY | 300.18 Million CNY | -40.24% |
| 2022 Q4 | 300.18 Million CNY | -0.29% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q2 | 302.33 Million CNY | 0.0% |
| 2021 Q4 | 502.27 Million CNY | -37.38% |
| 2021 Q3 | 802.08 Million CNY | 165.3% |
| 2021 FY | 502.27 Million CNY | 151.14% |
| 2020 Q1 | 250 Million CNY | 0.0% |
| 2020 FY | 200 Million CNY | 0.0% |
| 2020 Q4 | 200 Million CNY | 0.0% |
| 2020 Q2 | 250 Million CNY | 0.0% |
| 2020 Q3 | 200 Million CNY | -20.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |